Bank of New York Mellon Corp Has $52.34 Million Stake in IonQ, Inc ...
π¦ Bank of New York Mellon Corp increased its IonQ stake by 4.5% to 1,815,366 shares worth $52.34 million in Q1.
π Accent Capital Management LLC raised its position by 171.8%, while Fortitude Family Office LLC surged 3,800% in holdings during Q4.
π IonQ reported a loss of ($0.34) EPS for the quarter, missing analyst estimates of ($0.26).
π° Revenue reached $64.67 million, beating estimates of $49.75 million and growing 754.7% year-over-year.
π― Northland Securities raised its price target to $70.00 with an 'outperform' rating.
βοΈ JPMorgan Chase increased its target to $50.00 but maintained a 'neutral' rating on the stock.
π Weiss Ratings upgraded IonQ from 'sell (d-)' to 'sell (d+)', while Wall Street Zen moved from 'strong sell' to 'sell'.
π Director Kathryn K. Chou sold 2,757 shares at $55.02, reducing her position by 4.22%.
π Director Gabrielle B. Toledano sold 2,757 shares at $55.01, cutting her stake by 19.82%.
π Insiders have collectively sold 13,102 shares valued at $701,489 over the last ninety days.
π The stock has a negative PE ratio of -121.84 and a high beta of 3.23 indicating volatility.
π΅ The company's market capitalization is currently valued at $12.73 billion.
- IonQ significantly beat revenue expectations, reporting $64.67 million against an analyst estimate of $49.75 million.
- Revenue grew by 754.7% year-over-year, demonstrating rapid business expansion in the quantum computing sector.
- Northland Securities raised its price objective to $70.00 and issued an 'outperform' rating.
- JPMorgan Chase increased its price target from $42.00 to $50.00 despite a neutral rating.
- Institutional ownership remains strong at 41.42%, with major firms like BNY Mellon increasing stakes.
- The stock has shown significant volatility with a twelve-month high of $84.64, indicating potential upside.
- IonQ reported a loss of ($0.34) per share for the quarter, missing the consensus estimate of ($0.26).
- The company has a negative return on equity of -23.20% and a negative PE ratio of -121.84.
- Recent insider selling activity includes directors reducing positions by over $300,000 combined in late June.
- Total insider sales reached $701,489 in the last ninety days, signaling potential lack of confidence from management.
- Weiss Ratings upgraded IonQ only marginally from 'sell (d-)' to 'sell (d+)', maintaining a negative outlook.
- Wall Street Zen downgraded the stock from 'strong sell' to 'sell', reflecting ongoing analyst caution.